No abstract available
MeSH terms
-
Abscess / drug therapy
-
Abscess / etiology
-
Abscess / microbiology
-
Abscess / surgery
-
Adult
-
Amikacin / therapeutic use
-
Anti-Bacterial Agents / therapeutic use
-
Clarithromycin / therapeutic use
-
Combined Modality Therapy
-
Cosmetic Techniques / adverse effects*
-
Disease Outbreaks*
-
Drainage
-
Female
-
Humans
-
Injections, Intradermal / adverse effects*
-
Materia Medica / administration & dosage
-
Materia Medica / therapeutic use
-
Mycobacterium Infections, Nontuberculous / drug therapy
-
Mycobacterium Infections, Nontuberculous / epidemiology
-
Mycobacterium Infections, Nontuberculous / etiology*
-
Mycobacterium Infections, Nontuberculous / surgery
-
Nontuberculous Mycobacteria / isolation & purification*
-
Nontuberculous Mycobacteria / pathogenicity
-
Opportunistic Infections / drug therapy
-
Opportunistic Infections / epidemiology
-
Opportunistic Infections / etiology*
-
Opportunistic Infections / microbiology
-
Panniculitis / drug therapy
-
Panniculitis / epidemiology
-
Panniculitis / etiology*
-
Panniculitis / microbiology
-
Skin Ulcer / drug therapy
-
Skin Ulcer / etiology
-
Skin Ulcer / microbiology
-
Spain / epidemiology
-
Tuberculoma / drug therapy
-
Tuberculoma / etiology*
-
Tuberculoma / microbiology
-
Wound Infection / drug therapy
-
Wound Infection / etiology*
-
Wound Infection / microbiology
Substances
-
Anti-Bacterial Agents
-
Materia Medica
-
Amikacin
-
Clarithromycin